Literature DB >> 28930589

Procoagulant activity during viral infections.

Saravanan Subramaniam1, Inge Scharrer2.   

Abstract

The abundance of evidence suggest that inflammation of immune and non-immune cells may lead to an imbalance of the pro- and anti-coagulant state during viral infections. During systemic infections, the endothelium plays a critical role in regulating hemostasis, and severe imbalances of endothelial function and activation can contribute to organ failure. Viral infections may elevate plasma levels of procoagulant markers such as TAT and D-dimer TF-positive MPs as well as von Willebrand factor (vWF). Although multiple clinical studies are showing the association of viral infection and increased prothrombotic risk, the pathological mechanisms have not been fully identified for most viral infections. Viral infection mediated TLRs activation is both cell type- and species-specific and explains the difficulties in correlating murine model data with the human data. In this review, we briefly discuss the TF-dependent coagulation activation, Toll-like receptors (TLRs) signaling during viral infections, and their contributions to the procoagulant response.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28930589     DOI: 10.2741/4633

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  26 in total

Review 1.  Thrombosis in COVID-19.

Authors:  Thomas C Hanff; Amir M Mohareb; Jay Giri; Jordana B Cohen; Julio A Chirinos
Journal:  Am J Hematol       Date:  2020-09-16       Impact factor: 10.047

2.  A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C).

Authors:  Saravanan Subramaniam; Yamini Ogoti; Irene Hernandez; Mark Zogg; Fady Botros; Robert Burns; Jacob T DeRousse; Chris Dockendorff; Nigel Mackman; Silvio Antoniak; Craig Fletcher; Hartmut Weiler
Journal:  Blood Adv       Date:  2021-07-13

Review 3.  Could Low Doses Acetylsalicylic Acid Prevent Thrombotic Complications in COVID-19 Patients?

Authors:  Federico Cacciapuoti; Fulvio Cacciapuoti
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

Review 4.  Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19.

Authors:  Aaron Schmid; Marija Petrovic; Kavya Akella; Anisha Pareddy; Sumathilatha Sakthi Velavan
Journal:  Int J Vasc Med       Date:  2021-04-22

Review 5.  Thymoquinone: A Promising Natural Compound with Potential Benefits for COVID-19 Prevention and Cure.

Authors:  Osama A Badary; Marwa S Hamza; Rajiv Tikamdas
Journal:  Drug Des Devel Ther       Date:  2021-05-03       Impact factor: 4.162

6.  Correlation of Neuroimaging Findings with Clinical Presentation and Laboratory Data in Patients with COVID-19: A Single-Center Study.

Authors:  Seyhmus Kavak; Mehmet Serdar Yildirim; Rojhat Altındag; Yilmaz Mertsoy; Mehmet Fuat Alakus; Mehmet Diyaddin Guleken; Safak Kaya
Journal:  Biomed Res Int       Date:  2021-08-10       Impact factor: 3.411

7.  Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection.

Authors:  Franklin L Wright; Thomas O Vogler; Ernest E Moore; Hunter B Moore; Max V Wohlauer; Shane Urban; Trevor L Nydam; Peter K Moore; Robert C McIntyre
Journal:  J Am Coll Surg       Date:  2020-05-15       Impact factor: 6.113

8.  Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.

Authors:  Saravanan Subramaniam; Wolfram Ruf; Markus Bosmann
Journal:  Br J Pharmacol       Date:  2021-07-07       Impact factor: 8.739

Review 9.  The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.

Authors:  Nicola Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2021-07-01       Impact factor: 2.576

10.  Lung and kidney perfusion deficits diagnosed by dual-energy computed tomography in patients with COVID-19-related systemic microangiopathy.

Authors:  Ilkay S Idilman; Gulcin Telli Dizman; Selin Ardali Duzgun; Ilim Irmak; Musturay Karcaaltincaba; Ahmet Cagkan Inkaya; Figen Demirkazik; Gamze Durhan; Meltem Gulsun Akpinar; Orhan Macit Ariyurek; Erhan Akpinar; Jordi Rello; Murat Akova; Deniz Akata
Journal:  Eur Radiol       Date:  2020-08-29       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.